Safety and efficacy of catheter ablation for atrial fibrillation patients with history of renal transplantation

doi:10.3969/j.issn.1006-7795.2020.03.020

Abstract

Abstract: Objective To study the prognosis of catheter ablation in atrial fibrillation (AF) patients with history of renal transplantation. Methods Seven AF patients with renal transplantation history who had received radiofrequency ablation due to the poor effect of antiarrhythmic drugs were selected as the case group, and 42 controls were selected according to the 1:6 matching principle (age, gender and type of atrial fibrillation). The recurrence rate, perioperative complications and the incidence of contrast nephropathy were compared and analyzed. Results No periprocedural complications and contrast nephropathy were observed in either group. During a follow-up period of 12 months, the ATa recurrent rate was higher in AF patients with renal transplantation history (Log rank test, P=0.027). Conclusion Catheter ablation for AF can be safely performed in patients with history of renal transplantation. AF patients with renal transplantation history tend to have higher ATa recurrence after the catheter ablation.

Key words: atrial fibrillation, renal transplantation, estimated glomerular filtration rate, catheter ablation

CLC Number:

Yu Ronghui, Tang Ribo, Wu Jiahui, Wen Songnan, Lin Hui. Safety and efficacy of catheter ablation for atrial fibrillation patients with history of renal transplantation[J]. Journal of Capital Medical University, 2020, 41(3): 433-438.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2020.03.020

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2020/V41/I3/433

References

[1] Jun M, James M T, Manns B J, et al. The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment:population based observational study[J]. BMJ, 2015, 350:h246.
[2] Ng K P, Edwards N C, Lip G Y, et al. Atrial fibrillation in CKD:balancing the risks and benefits of anticoagulation[J]. Am J Kidney Dis, 2013, 62(3):615-632.
[3] Zimmerman D, Sood M M, Rigatto C, et al. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis[J]. Nephrol Dial Transplant, 2012, 27(10):3816-3822.
[4] Lentine K L, Schnitzler M A, Abbott K C, et al. Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation[J]. Clin J Am Soc Nephrol, 2006, 1(2):288-296.
[5] Schnuelle P, Lorenz D, Trede M, et al. Impact of renal cadaveric transplantation on survival in end-stage renal failure:evidence for reduced mortality risk compared with hemodialysis during long-term follow-up[J]. J Am Soc Nephrol, 1998, 9(11):2135-2141.
[6] Port F K, Wolfe R A, Mauger E A, et al. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients[J]. JAMA, 1993, 270(11):1339-1343.
[7] Ojo A O, Port F K, Wolfe R A, et al. Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients[J]. Am J Kidney Dis, 1994,24(1):59-64.
[8] Snyder J J, Kasiske B L, Gilbertson D T, et al. A comparison of transplant outcomes in peritoneal and hemodialysis patients[J]. Kidney Int, 2002, 62(4):1423-1430.
[9] Calkins H, Hindricks G, Cappato R,et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation[J]. Europace,2018,20(1):e1-e160.
[10] Ma Y C, Zuo L, Chen J H, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease[J]. J Am Soc Nephrol, 2006, 17(10):2937-2944.
[11] Ohno I, Hayashi H, Aonuma K, et al. Guidelines on the use of iodinated contrast media in patients with kidney disease 2012:digest version:JSN, JRS, and JCS Joint Working Group[J]. Clin Exp Nephrol, 2013, 17(4):441-479.
[12] Liu X, Dong J, Mavrakis H E, et al. Achievement of pulmonary vein isolation in patients undergoing circumferential pulmonary vein ablation:a randomized comparison between two different isolation approaches[J]. J Cardiovasc Electrophysiol, 2006, 17(12):1263-1270.
[13] Schweiger M J, Chambers C E, Davidson C J, et al. Prevention of contrast induced nephropathy:recommendations for the high risk patient undergoing cardiovascular procedures[J]. Catheter Cardiovasc Interv, 2007, 69(1):135-140.
[14] Lentine K L, Schnitzler M A, Abbott K C, et al. Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation[J]. Clin J Am Soc Nephrol, 2006, 1(2):288-296.
[15] Yamada T, Kay G N. Catheter ablation of atrial fibrillation in the elderly. Pacing Clin Electrophysiol[J]. 2009, 32(8):1085-1091.
[16] Chugh A, Morady F. Atrial fibrillation:catheter ablation[J]. J Interv Card Electrophysiol, 2006, 16(1):15-26.
[17] Cappato R, Calkins H, Chen S A, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation[J]. Circ Arrhythm Electrophysiol, 2010, 3(1):32-38.
[18] Wright M, Haïssaguerre M, Knecht S, et al. State of the art:catheter ablation of atrial fibrillation[J]. J Cardiovasc Electrophysiol, 2008, 19(6):583-592.
[19] Naruse Y, Tada H, Sekiguchi Y, et al. Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation:a mid-term follow-up[J]. Heart Rhythm, 2011, 8(3):335-341.
[20] Abbott K C, Reynolds J C, Taylor A J, et al. Hospitalized atrial fibrillation after renal transplantation in the United States[J]. Am J Transplant, 2003, 3(4):471-476.
[21] Margreiter R, European Tacrolimus vs Ciclosporin Microemulsion Renal Transplantation Study Group. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation:a randomised multicentre study[J]. Lancet, 2002, 359(9308):741-746.
[22] Berruezo A, Tamborero D, Mont L, et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation[J]. Eur Heart J, 2007, 28(7):836-841.
[23] Themistoclakis S, Schweikert R A, Saliba W I, et al. Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation[J]. Heart Rhythm, 2008, 5(5):679-685.
[24] Severi S, Pogliani D, Fantini G, et al. Alterations of atrial electrophysiology induced by electrolyte variations:combined computational and P-wave analysis[J]. Europace, 2010, 12(6):842-849.
[25] Rigatto C, Foley R N, Kent G M, et al. Long-term changes in left ventricular hypertrophy after renal transplantation[J]. Transplantation, 2000, 70(4):570-575.
[26] Chao T F, Lin Y J, Chang S L, et al. Associations between renal function, atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation[J]. Circ J, 2011, 75(10):2326-2332.
[27] Tanaka K, Zlochiver S, Vikstrom K L, et al. Spatial distribution of fibrosis governs fibrillation wave dynamics in the posterior left atrium during heart failure[J]. Circ Res, 2007, 101(8):839-847.